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The atrioventricular node (AVN) is a vital component of the pacemaker-conduction system of the heart,
co-ordinating conduction of electrical excitation from cardiac atria to ventricles and acting as a secondary
pacemaker. The electrical behaviour of the AVN is modulated by vagal activity via activation of musca-
rinic potassium current, IKACh. However, it is not yet known if this response exhibits ‘fade’ or desensitiza-
tion in the AVN, as established for the heart’s primary pacemaker – the sinoatrial node. In this study,
acute activation of IKACh in rabbit single AVN cells was investigated using whole-cell patch clamp at
37 C. 0.1–1 lM acetylcholine (ACh) rapidly activated a robust IKACh in AVN myocytes during a descend-
ing voltage-ramp protocol. This response was inhibited by tertiapin-Q (TQ; 300 nM) and by the M2 mus-
carinic ACh receptor antagonist AFDX-116 (1 lM). During sustained ACh exposure the elicited IKACh
exhibited bi-exponential fade (sf of 2.0 s and ss 76.9 s at 120 mV; 1 lM ACh). 10 nM ET-1 elicited a cur-
rent similar to IKACh, which faded with a mono-exponential time-course (s of 52.6 s at 120 mV). When
ET-1 was applied following ACh, the ET-1 activated response was greatly attenuated, demonstrating that
ACh could desensitize the response to ET-1. For neither ACh nor ET-1 was the rate of current fade depen-
dent upon the initial response magnitude, which is inconsistent with K+ ﬂux mediated changes in elec-
trochemical driving force as the underlying mechanism. Collectively, these ﬁndings demonstrate that
TQ sensitive inwardly rectifying K+ current in cardiac AVN cells, elicited by M2 muscarinic receptor or
ET-1 receptor activation, exhibits fade due to rapid desensitization.
 2012 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
The atrioventricular node (AVN) of the heart is situated at the
junction between the right atrium and ventricle [1] and is normally
the only route by which electrical excitation can pass from atria to
ventricles [2]. During atrial ﬁbrillation the slow conduction proper-
ties of the AVN limit impulse transmission to the ventricles, there-
by affording them some protection from an excessively fast
ventricular rate [2,3]. The AVN also possesses pacemaker proper-
ties and can take over ventricular pacing should the primary pace-
maker, the sinoatrial node (SAN), fail [2,4]. The electrophysiological
properties of the intact AVN depend on both the anatomy and elec-
trophysiology of the region [2,5] and the cellular electrophysiology
of different sub-regions of the AVN depends on the interplay be-
tween a range of ion channel currents [6–8].
Vagal stimulation or application of acetyl-choline (ACh) pro-
duces negative dromotropic and chronotropic effects on the AVN
[2]. Activation of G-protein dependent, inwardly rectifying
Kir3.1/3.4 channels is important to the cardiac actions of ACh
[9,10]. Application of cholinergic agonists to small multicellularY-NC-ND license. 
ncox).AVN preparations or to single AVN cells activates an inwardly rec-
tifying K+ current, IKACh which decreases excitability [7,11–14],
contributing to suppression of spontaneous activity [12,13] and,
in perfused intact hearts, to AV conduction block [15]. In the
SAN, IKACh (likely carried by Kir3.1/3.4; [10]) contributes signiﬁ-
cantly to the negative chronotropic effect of ACh [16] and SAN IKACh
activation ‘fades’ in the continuous presence of ACh [17]. However,
there is disagreement as to whether or not vagal responses of the
AVN exhibit a ‘fade’ phenomenon. For example, in one study the
negative dromotropic response of anaesthetised dogs to tonic vagal
stimulation was reported to exhibit fade when the initial response
to vagal stimulation was large [18], whilst in a separate study dro-
motropic effects of ACh in anaesthetised dogs were reported not to
fade during maintained cholinergic activation [19]. On the other
hand, vagal stimulation of rabbit isolated atrial preparations from
which SAN and AVN responses were monitored simultaneously
has been reported to produce membrane hyperpolarization that
exhibited similar fade in both regions [20]. We have recently ob-
served transient activation in isolated AVN myocytes of a tertia-
pin-Q sensitive inwardly rectifying IKACh-like current by the
peptide hormone ET-1 [21]. This raises the possibility that musca-
rinic activation of IKACh in myocytes from the AVN is followed by
fade/desensitization of the response. The present study was con-
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preparation from the rabbit heart [13].2. Methods
2.1. Rabbit AVN cell isolation
Male White New-Zealand rabbits (2.0–3.5 kg) were killed in
accordance with the United Kingdom Home Ofﬁce Animals Scien-
tiﬁc Procedures Act (1986). Their hearts were rapidly excised and
cells isolated from the entire atrioventricular nodal (AVN) region
as described previously [13,22,23]. Isolated AVN cells were stored
in Kraft-Brühe ‘‘KB’’ solution [13,24] at 4 C until use.
2.2. Electrophysiological recording
Cells were placed in an experimental chamber (0.5 ml)
mounted on the stage of an inverted microscope (Nikon Diaphot)
and superfused with a normal Tyrode’s solution, containing (in
mM): NaCl 140, KCl 4, CaCl2 2, MgCl2 1, HEPES 5 and Glucose 10,
(pH 7.4 with NaOH). ACh, ET-1 and other compounds were added
to this solution. Patch-pipettes (Corning 7052 glass, AM Systems
Inc., Sequim, WA, USA) were pulled using a P-97 Flaming/Brown
micropipette puller (Sutter Instruments, Novato, CA, USA) and
were ﬁlled with a pipette solution containing (in mM) [23,25]:
KCl 110, NaCl 10, HEPES 10, MgCl2 0.4, and Glucose 5, K2ATP dihy-
drate 5, GTP-Tris salt 0.5, BAPTA 5, pH 7.1 with KOH. Recordings
were made using an Axopatch 1D ampliﬁer (Axon Instruments;
now Molecular Devices, Sunnyvale, CA, USA). Pipette resistance
was typically <3 MX; series resistance was typically compensated
by 60–80%. Under voltage clamp, membrane potential was held
at 40 mV as this value corresponds to the zero current potential
for rabbit AVN cells (e.g. [13,26]). Electrophysiological protocols
were generated and data recorded using Clampex 8 (Axon Instru-
ments; CA, USA). Repetitive application of a descending voltage
ramp protocol (shown in the left panel of Fig. 1A) was used to sur-
vey rapidly current between +20 and 120 mV. A brief (50 ms)
step from 40 to +20 mV preceded the descending ramp in the
voltage protocol. The initial depolarizing step phase of the protocol
elicited an L-type calcium current (ICa,L), which was used as an
independent marker of AVN cell responsiveness to ACh (and ET-
1), as both receptor agonists inhibit AVN ICa,L (e.g.[12,13,21]).
2.3. Solutions and chemicals
Cells were superfused with experimental solutions at 35–37 C
(checked regularly using a hand-held thermocouple). ACh, ET-1
and other compounds were applied externally to the cell under
study using a home-built, rapid solution exchange device capable
of exchanging superfusate in <1 s [27]. ACh (Sigma–Aldrich Com-
pany Ltd., Dorset, UK) was used at 0.1 and 1 lM from a stock solu-
tion (1 or 10 mM) made each experimental day in distilled,
deionized water. ET-1 (Sigma–Aldrich Company Ltd., Dorset, UK)
was used at 10 nM from a stock solution of 100 lM prepared in
0.1% acetic acid. Tertiapin-Q (Tocris Bioscience, Bristol, UK) was
prepared in deionised water and used at a ﬁnal concentration of
300 nM in Tyrode’s solution. AFDX-116 (Ascent Scientiﬁc, Bristol)
was used at 1 lM from a stock solution made in DMSO. All drug
stocks except ACh were aliquoted and stored at 20 C.
2.4. Data analysis
Data were analysed and graphical plots produced using Clamp-
ﬁt 10.2 software (Molecular Devices Sunnyvale, CA, USA), Micro-
soft Excel (2003) and GraphPad Prism (v5; GraphPad SoftwareInc., La Jolla, CA, USA). Data are presented as mean ± standard error
of the mean (SEM). Statistical analysis was performed using Stu-
dent’s t-test, one-way ANOVA with a Bonferroni post hoc test. Val-
ues of ‘p’ less than 0.05 were taken as signiﬁcant.3. Results and discussion
One micromolar of ACh was employed to elicit IKACh in this
study, as this concentration has been established to produce a ro-
bust activation of AVN cell IKACh [7], leading to rapid membrane po-
tential hyperpolarisation and quiescence in AVN cell and tissue
preparations [12,13]. Fig. 1A (right panel) shows representative
currents during the descending ramp phase of the command proto-
col plotted against voltage, obtained in normal Tyrode’s solution
and immediately following rapid application of ACh. One micromo-
lar of ACh increased current across the entire range of measured
voltages. In ACh the net current during the ramp exhibited marked
inward rectiﬁcation and reversed slightly negative to 80 mV.
Fig. 1B shows the mean current density–voltage (IV) relation
for the maximal ACh-activated current, IKACh (n = 6). The mean
reversal potential (Erev) for this current was 85.5 ± 0.6 mV. In
additional experiments, IKACh was activated by a lower ACh concen-
tration (0.1 lM); the current proﬁle was similar to that produced
by 1 lM ACh, but was of smaller magnitude. The M2 receptor is
considered to be the predominant muscarinic receptor sub-type
in mammalian heart [28]. When AVN cells were pre-treated with
the M2 receptor inhibitor AFDX-116 (1 lM), the response to
1 lMACh was largely abolished (Fig. 1C), demonstrating M2 recep-
tor activation to be responsible for generation of AVN IKACh. This is
concordant with: (i) prior work on anaesthetised dogs in which
AFDX-116 inhibited chronotropic and dromotropic responses to
intracardiac vagal nerve stimulation [29]; (ii) the persistence of
AV conduction block in response to intravenous ACh in mice deﬁ-
cient in M1-receptors [30], and (iii) presumed M2-receptor medi-
ated conduction effects of propofol on guinea-pig hearts [31].
SAN IKACh is sensitive to the bee venom toxin tertiapin [32,33]. To
our knowledge, there are no similar data for AVN IKACh per se,
although ACh effects on guinea-pig atrio-ventricular conduction
have been shown to be sensitive to tertiapin [15]. When we ap-
plied ACh to cells after exposure to tertiapin Q (300 nM), IKACh
was largely abolished (Fig. 1C). Collectively, the data in Fig. 1 dem-
onstrate that rabbit AVN IKACh is tertiapin-Q sensitive and involves
ACh binding to M2 muscarinic receptors.
Fig. 2 shows the time-course of the effect of sustained exposure
to 1 lM ACh. Fig. 2A and B show representative time-plots for cur-
rent at two voltages (+20 and 120 mV) during the voltage ramp
protocol. It is clear that at both voltages ACh application led to a
maximal response within seconds of its application. However, in
the maintained presence of ACh the current response declined over
2 min, with an initial rapid decline followed by a slower second
phase. In six experiments the peak response at 120 mV was
37.6 ± 5.1 pA/pF, whilst after 2 min of ACh application the re-
sponse declined to an amplitude of 16.9 ± 0.8 pA/pF (p < 0.01).
At +20 mV, the peak response amplitude was 21.0 ± 2.6 pA/pF,
declining to 9.3 ± 1.1 pA/pF at 2 min of ACh application (p < 0.01).
Thus, acute activation of AVN IKACh exhibited rapid bi-phasic ‘fade’.
This was quantiﬁed by bi-exponential ﬁtting of the decline of net
current at each voltage; data from individual cells at each time-
point were normalised to maximal current in ACh, and then
pooled. Fits to the mean data are shown in Fig. 2C (at +20 mV)
and 2D (at 120 mV). At 120 mV 62.2 ± 6.7% of the current de-
cline was described by a time-constant (sf) of 2.0 s, whilst the
remainder of the current decline was described by a time-constant
(ss) of 76.9 s (see Fig. 2 legend for further numerical information).
In contrast to the situation for IKACh, ICa,L elicited by the +20 mV
AB
C
Fig. 1. Activation of AVN IKACh and sensitivity to M2 receptor inhibition and tertiapin-Q (A) Left panel shows voltage protocol used: from a holding potential of 40 mV, a step
to +20 mV for 50 ms preceded a descending voltage-ramp to 120 mV over 250 ms. The start-to-start interval between successive applications of the protocol was 2 s. Right
panel shows representative currents elicited in control (normal Tyrode’s) solution (black trace) and immediately following rapid superfusion of 1 lM ACh (grey trace). (B)
Mean current–voltage (I–V) relation for current activated by 1 lM ACh (n = 6; obtained by digital subtraction of current in control from that in ACh and normalised to cell
membrane capacitance). The black trace denotes the mean current values at each voltage, with grey traces indicating ±SEM values. (C) Mean current–density (pA/pF) of the
maximal IKACh at 120 mV (1 lM ACh sensitive current) in the presence of ACh alone (black bar; n = 6), with 1 lM of the M2 muscarinic receptor inhibitor AFDX-116 (grey
bar; n = 5), and in the presence of 300 nM of the GIRK channel inhibitor tertiapin-Q (white bar; n = 6). Asterisks denote statistically signiﬁcant differences (⁄⁄⁄p < 0.001).
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with 1 lM ACh application (not shown), declining by 41.7 ± 6.0%
(n = 6) of its initial amplitude by 2 min following the peak IKACh
response. The biphasic nature of the fade of AVN cell IKACh in this
study correlates qualitatively with a reported biphasic decline of
hyperpolarising response of the rabbit intact AVN to trains of vagal
nerve stimuli [20], although in absolute terms the time-course of
the observed fade of the intact node membrane potential responsewas faster than that seen here [20]. Differences in time-course of
response decline between that study and this one are likely to be
accounted for by the different preparations used (intact tissue ver-
sus isolated cell) and mode and duration of vagal activation (vagal
nerve stimulation versus sustained superfusion of ACh).
Recent data from experiments conducted using voltage-step
protocols have shown that ET-1, acting through the ETA receptor,
transiently activates a tertiapin-Q sensitive K+ current that resem-
A C
B D
Fig. 2. Time-course of fade of the ACh response. (A and B) show representative continuous time-plots of current at +20 mV (A) and 120 mV (B) before and during exposure
to 1 lM ACh. Time of ACh application is denoted by the horizontal bar in panel A. (C and D) showmean data-plots (n = 6) in which for each cell the net current amplitude was
normalised to the maximum response in the presence of ACh at +20 mV (C) and 120 mV (D). Data were ﬁtted by a two-phase decay equation. At +20 mV 56.1 ± 8.8% of the
declining current was characterised by a fast rate of decline (Kfast) of 0.67 ± 0.42 s1 (equivalent to a sf of 1.5 s) whilst the remainder of current decline was characterised by a
slow rate of decline (Kslow) of 0.029 ± 0.012 s1 (equivalent to a ss of 34.5 s). At 120 mV 62.2 ± 6.7% of current decline was characterised by a Kfast of 0.50 ± 0.20 s1 (p > 0.7
versus +20 mV; equivalent to a sf of 2 s), whilst the remainder of current decline was characterised by a Kslow of 0.013 ± 0.011 s1 (p > 0.3; equivalent to a ss of 76.9 s).
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tions on IKACh, we conducted experiments with ET-1 using the same
voltage protocol used to study ACh. Fig. 3A shows the time-course
of current activation by ET-1 at +20 and 120 mV during the volt-
age ramp protocol. At both voltages ET-1 application led to a max-
imal response within seconds of its application (mean I–V data for
peak ET-1 activated current are shown in Fig. 3B, showing the re-
sponse to be very similar to that to ACh (Fig. 1B), though of smaller
magnitude). Also similar to ACh, in the maintained presence of ET-
1 the response magnitude declined over a 2–3 min recording per-
iod. This is shown for an individual experiment in Fig. 3A and in
Fig. 3C and D for mean data (normalised to maximal response
amplitude as for ACh in Fig. 2). The rate of decline of the ET-1 re-
sponse could be described satisfactorily by a single exponential
function, with time-constant values of 55.5 and 52.6 s respectively
at +20 and 120 mV. As reported recently [21], 10 nM ET-1 also
produced a monotonic decrease in the amplitude ICa,L elicited by
the +20 mV voltage step (declining by 69.7 ± 3.3% (n = 6) at
2 min of exposure).
Acute desensitization of IKACh in rat atrial myocytes has been
proposed to depend on K+ ion ﬂow and to arise due to an acute
reduction in electrochemical driving force for K+ ion ﬂow rather
than from changes to receptor-coupled signalling [34]. If such an
explanation applies to AVN cells, then the magnitude of peak re-
sponse to ACh (representing an index of K+ ﬂux) might be expected
to determine the rate of subsequent current decline. Fig. 4A and B
respectively show plots of the sf and ss of decline of ACh responsesagainst the initial peak magnitude of the current response, incor-
porating data with both 0.1 and 1 lM ACh (respectively, open
and ﬁlled symbols). There was no signiﬁcant correlation between
either time constant and the initial response amplitude (r of 0.0
for sf and 0.4 for ss, with respective p values of 1.0 and 0.2).
Fig. 4C shows similar data for ET-1, demonstrating little correlation
between fade time constant and initial response amplitude (r of
0.09, p of 0.9). Thus, regardless of the receptor system by which
IKACh was activated, there was no relation between the rate of fade
and the magnitude of K+ ﬂux. In addition, were a change in the
electrochemical driving force for K+ ﬂow to result from activation
of AVN IKACh, this might be expected to be reﬂected in a positive
shift in the reversal potential for the current during continued
application of the agonist. Fig. 4D shows plots of Erev for the
1 lM ACh-activated current at the time-point of peak response to
ACh and at 6 s after the initial peak (at which time-point any initial
decline would have been attributable to the fast component of cur-
rent fade) and after 2 min of ACh application (by which time-point
both fast and slow fade would have occurred). The values obtained
at the three time points did not differ signiﬁcantly, indicating that
statistically signiﬁcant changes in electrochemical driving force
(and thereby Erev) had not occurred (p > 0.1). In this regard our re-
sults are similar to those from a prior study of guinea-pig atrial
myocytes, in which biphasic fade of IKACh occurred with no alter-
ation in Erev for the current [35]. Thus, it can be concluded that,
in contrast to the mechanism proposed for rat atrial myocytes by
Bender et al. [34], the fade of IKACh in AVN cells does not depend
A C
B
D
Fig. 3. Fade of ET-1 activated K+ current. (A) shows representative continuous time-plots of current at +20 mV (upper panel) and 120 mV (lower panel) before and during
exposure to 10 nM ET-1. Time of ET-1 application is denoted by the horizontal bar in upper panel. Voltage protocol same as Fig. 1A. (B) shows mean current density–voltage
relation for ET-1 activated current (n = 6). (C, D) show mean data indicating time-course of decline of response to ET-1 at +20 mV (C) and 120 mV (D). Data were normalised
as for ACh in Fig. 2. The fade in response exhibited monophasic decline with rate constants of 0.018 ± 0.001 s1 and 0.019 ± 0.001 s1 for +20 and 120 mV, respectively
(p > 0.4; equivalent to s values of 55.5 and 52.6 s).
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sponse to ACh.
In a ﬁnal set of experiments, we investigated whether or not
ACh was able to cause desensitization of the response to ET-1. In
these experiments 1 lM ACh was applied and after the response
had exhibited considerable fade (with at least two minutes of
ACh exposure), ET-1 was then rapidly applied in the maintained
presence of ACh. Fig. 4E shows representative traces of the ACh-
sensitive current at the peak of the ACh response (black trace)
and after 2 min in the presence of ACh (light grey trace). Also
superimposed is the peak ET-1-sensitive current following subse-
quent ET-1 application (dark grey trace): it is notable that under
these conditions relatively little additional current was activated
by ET-1. Fig. 4F shows the mean current density at 120 mV of
ACh-activated and ET-1 activated current (when each agonist
was applied separately), together with the mean ET-1 activated
current density for cells receiving prior ACh exposure. The small
size of the ET-1 activated current following exposure to ACh in
comparison to the response to ET-1 alone indicates that ACh and
ET-1 responses are not simply additive. Furthermore, once the
ACh response had faded, the affected channels appeared to be rel-
atively unresponsive to ET-1. Thus, it can be concluded that ACh
causes desensitization not only of the ACh-sensitive K+ current
but also of the ET-1-sensitive K+ current (this was not the case
for ICa,L, which was still able to respond to ET-1 with a66.0 ± 8.0% (n = 6) decline, following prior ACh exposure (data
not shown; not signiﬁcantly different from extent of reduction
without ACh pre-treatment; p > 0.6)). This observation suggests
that despite working through different receptors, ET-1 and ACh
share pathways of action downstream from the receptors and
likely elicited their responses by acting on the same pool of K+
channels; furthermore once the ACh response had faded, the af-
fected channels appeared to be relatively unresponsive to ET-1.
To our knowledge, this may constitute the ﬁrst report for any re-
gion of the heart of cross-desensitization by ACh of the cardiac
G-protein-dependent inwardly rectifying current activated by an
agonist of a distinct receptor.
In conclusion, this study establishes that both M2 muscarinic
receptor and ET-1 activated ‘‘IKACh’’ in AVN cells exhibit marked
fade during continuous exposure to ACh and ET-1. The two differ-
ent receptor agonists appear to act on the same underlying K+
channel pool. Acute fade of IKACh is not explicable as a consequence
of K+ ﬂux mediated alterations to electrochemical K+ driving force.
Rather it is likely to involve desensitization of the receptor/signal-
ling pathway. Involvement of a receptor-linked mechanism is also
consistent with differences in the time-course of fade of 10 nM ET-
1 and 1 lMACh responses; such differences would not be expected
from a mechanism depending purely on K+ ion ﬂux. Muscarinic
receptor-mediated inhibition of AVN basal ICa,L has been proposed
to involve suppression of cAMP synthesis [36] or nitric-oxide mod-
A B C
FED
Fig. 4. Relationship between K+ current response magnitude and decline rate, and effect of combined ACh and ET-1 application. (A and B) Plots of time constants of current
fade (A: sfast (sf); B sslow (ss)) against magnitude of initial response to 1 lM ACh (n = 6; ﬁlled circles). Open circles show data for 0.1 lM ACh. For this concentration of ACh 3
cells exhibited biphasic decay and 3 cells monophasic decay; for the latter, the single s values are plotted in B. (C) Plot of time constant of current fade against magnitude of
initial response to 10 nM ET-1 (n = 6; ﬁlled circles). (A)–(C) time-course measured for responses at 120 mV. (D) Plot of Erev for IKACh activated by 1 lM ACh at the initial peak
of the response (black bar), at 6 s following the maximal response (grey bar) and at 2 min following maximal response (open bar). There was no signiﬁcant difference in Erev
values at the different time-points (n = 6; p > 0.1). (E and F) Effects of 10 nM ET-1 following prior exposure to 1 lM ACh. (E) shows representative currents (plotted as current
density against voltage) for responses in the same cell to 1 lM ACh (IKACh) measured as ACh-activated current at maximal response (black trace) and 2 min after the maximal
response (light grey trace). The dark grey trace shows maximal current in 10 nM ET-1 (plotted as ET-1 activated current compared to control) following 2 min exposure to
ACh. In the concomitant presence of ACh, ET-1 elicited little additional current. (F) Maximal current densities for current at 120 mV for ACh-activated current (black bar;
n = 6), ET-1 (grey bar; n = 6,) and the ET-1 difference current (ET-1 minus ACh) when ET-1 was applied following fade of the ACh response. Asterisks denote statistical
signiﬁcance (⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001).
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fade of the response of ICa,L to ACh in the present study suggests
that these pathways are unlikely to be involved in AVN IKACh
fade/desensitization. Cardiac muscarinic K+ current desensitization
has been suggested to involve mechanisms involving G protein-
coupled receptor kinase (GRK2), b arrestin and M2 receptor inter-
nalisation (e.g. [37–40]). Further work is required to elucidate the
contributions of such mechanisms to AVN cell IKACh desensitiza-
tion. However, the fact that in our experiments the inhibitory ef-
fects of ACh and ET-1 on ICa,L were sustained in the same cells in
which IKACh fade occurred, suggests either that rapid receptor inter-
nalisation was not responsible for desensitization of the AVN cell
K+ current response in our experiments, or that the M2 receptors
coupled to channels modulating ICa,L and IKACh reside in different
pools. Rapid cross-desensitization of ET-1 activated K+ current by
prior ACh exposure is likely to occur down-stream of the ET-1
receptor itself, but could feasibly involve GRK2 linked desensitiza-
tion of those ETA receptors coupled to K+ channels [41,42]. Fade of
IKACh may provide a mechanism for physiological adaptation of the
AVN to cholinergic stimulation [20,43]. Further investigation of
this phenomenon and of the mechanism(s) underlying desensitiza-
tion is now warranted.
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